-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
-
Summary
-
Petros Pharmaceuticals, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from Q3 2020 to Q2 2024.
- Petros Pharmaceuticals, Inc. Earnings Per Share, Basic for the quarter ending June 30, 2024 was -0.37 USD/shares, a 69.2% increase year-over-year.
- Petros Pharmaceuticals, Inc. Earnings Per Share, Basic for the twelve months ending June 30, 2024 was -6.55 USD/shares, a 38.1% increase year-over-year.
- Petros Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2023 was -6.35 USD/shares, a 34.4% increase from 2022.
- Petros Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2022 was -9.68 USD/shares, a 17.3% decline from 2021.
- Petros Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2021 was -8.25 USD/shares, a 114% decline from 2020.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)